I have Type 1 diabetes. I love to write. I’m happy when I am helping others. I speak up when it’s important. I have a passion for sharing knowledge and learning new technology. I was BORN to BLOG!

I’ve met so many other T1Ds on this journey who are cool and love to help others. We put our heads and hearts together … to bring more resources and knowledge to our amazing diabetes community. We’re making improvements every day … come back often, let us know what you think. And my gratitude for my amazing webmaster, Dave (an honorary T1D)!

And thank you for stopping by!
— Joanne Laufer Milo, The Savvy Diabetic

Savvy Updates 6/20/22: Study to Regenerate Beta Cells, Senseonics Eversense E3 180-day CGM Gets CE Mark, Piezoelectric Button to Control T1D, Insulin & Weight Gain, Lager Beer Improves Gut Health, Best Time to Exercise Differs by Sex, Recession Impact on Medical Device Growth

Savvy Updates 6/20/22: Study to Regenerate Beta Cells, Senseonics Eversense E3 180-day CGM Gets CE Mark, Piezoelectric Button to Control T1D, Insulin & Weight Gain, Lager Beer Improves Gut Health, Best Time to Exercise Differs by Sex, Recession Impact on Medical Device Growth

by | Jun 20, 2022 | , , | 3 Comments

New potential diabetes treatment regenerates insulin-producing cells was written by Michael Irving for NewAtlas.com, 13 June 2022. An emerging way to treat diabetes is to repair or replace the cells in the body that naturally produce insulin. Swedish researchers have...

read more
Savvy Updates, 6/6/22: Abbott Libre 3 & Lingo, Diabeloop $$, iLet Bionic Pancreas Trial, Apple Watch BG Monitoring, Medtronic Struggles, Diabetes & Long Covid, Dexcom Denies Rumors, Pharmacy Benefit Managers Cost Consumers

Savvy Updates, 6/6/22: Abbott Libre 3 & Lingo, Diabeloop $$, iLet Bionic Pancreas Trial, Apple Watch BG Monitoring, Medtronic Struggles, Diabetes & Long Covid, Dexcom Denies Rumors, Pharmacy Benefit Managers Cost Consumers

by | Jun 6, 2022 | , , | 1 Comment

ABBOTT NEWS US FDA approves Abbott’s FreeStyle Libre 3 system for diabetic patients was reported by MedicalDevice-Network.com, 1 June 2022.   The US Food and Drug Administration (FDA) has granted clearance to Abbott’s next-generation FreeStyle...

read more
Savvy Updates 5/30/22: Dexcom-Insulet Purchase Discussion, Medtronic’s Continuing Supply Chain Woes, Levicure Ltd Aims for Oral Treatment for T1D

Savvy Updates 5/30/22: Dexcom-Insulet Purchase Discussion, Medtronic’s Continuing Supply Chain Woes, Levicure Ltd Aims for Oral Treatment for T1D

by | May 30, 2022 | , , | 1 Comment

How a Dexcom-Insulet combination would shake up the diabetes treatment industry was published by Ricky Zipp for MedTechDive.com, 25 May 2022.   After last year’s barrage of deal-making in the medical device industry, there have been few acquisitions in...

read more
Savvy Updates 5/23/22: Evotec/Sernova Beta Cell Replacement Therapy for Cure to Diabetes, How Kidneys Actually Work, Neuropathy & Diabetes Fatigue

Savvy Updates 5/23/22: Evotec/Sernova Beta Cell Replacement Therapy for Cure to Diabetes, How Kidneys Actually Work, Neuropathy & Diabetes Fatigue

by | May 23, 2022 | , , | 1 Comment

Evotec, Sernova Striving for Functional Diabetes Cure was published by Alex Keown for BioSpace.com, 17 May 2022. Two life sciences powerhouses are coming together to develop an off-the-shelf beta cell replacement therapy for insulin-dependent diabetes patients,...

read more
Share This
Skip to content